The estimated Net Worth of Paul Jansen is at least 2.1 百万$ dollars as of 8 March 2017. Paul Jansen owns over 55,611 units of Masimo Corp stock worth over 2,099,840$ and over the last 14 years Paul sold MASI stock worth over 0$.
Paul has made over 13 trades of the Masimo Corp stock since 2015, according to the Form 4 filled with the SEC. Most recently Paul exercised 55,611 units of MASI stock worth 1,335,776$ on 8 March 2017.
The largest trade Paul's ever made was exercising 55,611 units of Masimo Corp stock on 8 March 2017 worth over 1,335,776$. On average, Paul trades about 10,706 units every 33 days since 2011. As of 8 March 2017 Paul still owns at least 18,389 units of Masimo Corp stock.
You can see the complete history of Paul Jansen stock trades at the bottom of the page.
Paul's mailing address filed with the SEC is C/O MASIMO CORPORATION 40 PARKER, , IRVINE, CA, 92618.
Over the last 17 years, insiders at Masimo Corp have traded over 198,004,099$ worth of Masimo Corp stock and bought 212,683 units worth 10,354,127$ . The most active insiders traders include Joe E Kiani、Edward L Cahill、Yongsam Lee. On average, Masimo Corp executives and independent directors trade stock every 14 days with the average trade being worth of 2,669,077$. The most recent stock trade was executed by Joe E Kiani on 8 August 2024, trading 231,748 units of MASI stock currently worth 8,769,344$.
masimo (nasdaq: masi) is a global medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies, including medical devices and a wide array of sensors. our work is making a measurable difference in the world by saving, extending and improving the lives of people of all ages, in all walks of life for more than 27 years, our innovative medical technologies and noninvasive patient monitoring solutions have been solving ‘unsolvable’ problems. the result is a portfolio of clinically-proven products that lead the way in innovation, performance and patient safety by giving health care providers the information they need to optimize clinical decision-making. masimo is for‘what-ifers’, ‘never-say-never-ers’, and ‘world changers’—people who look beyond what others see. we're looking for people who can, do, and will make a difference. we think you'll like what you see.
Masimo Corp executives and other stock owners filed with the SEC include: